Skip to main content

Odomzo Side Effects

Generic name: sonidegib

Medically reviewed by Drugs.com. Last updated on Jul 27, 2024.

Note: This document provides detailed information about Odomzo Side Effects associated with sonidegib. Some dosage forms listed on this page may not apply specifically to the brand name Odomzo.

Applies to sonidegib: oral capsule.

Important warnings This medicine can cause some serious health issues

Oral route (capsule)

Use of sonidegib during pregnancy can cause embryofetal death or severe birth defects.

Verify pregnancy status prior to initiating treatment and advise females of reproductive potential to use adequate contraception during treatment and for at least 20 months after discontinuation.

Male patients with a female partner of reproductive potential must be advised to use adequate contraception during treatment for at least 8 months after discontinuation.

Precautions

It is very important that your doctor check your progress at regular visits for any unwanted effects or problems that may be caused by this medicine. Blood and urine tests may be needed to check for unwanted effects.

Using this medicine while you are pregnant can harm your unborn baby. If you are a woman who can bear children, your doctor may give you a pregnancy test before you start using this medicine to make sure you are not pregnant. Use a highly effective form of birth control to keep from getting pregnant. You should not become pregnant while you are taking this medicine and for 20 months after stopping it. If you think you have become pregnant while using the medicine, tell your doctor right away.

This medicine may also cause birth defects if the father is using it when his sexual partner becomes pregnant. Male patients (including those who had a vasectomy) should use condoms and spermicides as forms of birth control during sexual intercourse while taking sonidegib (the active ingredient contained in Odomzo) and for 8 months after the last dose of this medicine.

Do not donate blood or blood products while taking this medicine and for 20 months after stopping it. Men should not donate semen while taking this medicine and for 8 months after the last dose.

This medicine may increase your risk of serious muscle problems called rhabdomyolysis, that can lead to kidney damage. Tell your doctor right away if you develop new or worsening muscle spams, pain, or tenderness, dark urine, or decreased amount of urine while taking sonidegib.

If you plan to have children, talk with your doctor before using this medicine. Some women using this medicine have become infertile (unable to have children).

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal (eg, St John's wort) or vitamin supplements.

Serious side effects of Odomzo

Along with its needed effects, sonidegib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking sonidegib:

More common side effects

  • difficulty with moving
  • joint pain
  • muscle aching or cramping
  • muscle pains or stiffness
  • muscle spasms
  • swollen joints

Rare side effects

  • dark-colored urine
  • fever
  • muscle stiffness
  • unusual tiredness or weakness

Other side effects of Odomzo

Some side effects of sonidegib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

For healthcare professionals

Applies to sonidegib: oral capsule.

Musculoskeletal adverse events

75% of patients with increased serum creatinine had levels that remained within normal range.[Ref]

Dermatologic

Metabolic

Nervous system

Gastrointestinal

Other

Hematologic

Hepatic

Endocrine

See also:

References

1. Cerner Multum, Inc. "Australian Product Information."

2. (2015) "Product Information. Odomzo (sonidegib)." Novartis Pharmaceuticals

Frequently asked questions

Further information

Odomzo side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.